dock_to_right dock_to_right arrow_back

Terminology chevron_right Concepts chevron_right 1197400002

Production

Component

1197400002

The component that hold information about this concept.

Fully Specified Name (FSN)

Product containing precisely dolutegravir (as dolutegravir sodium) 50 milligram and lamivudine 300 milligram and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 milligram/1 each conventional release oral tablet (clinical drug)

Shortest Term

Dolutegravir (as dolutegravir sodium) 50 mg and lamivudine 300 mg and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 mg oral tablet

Definition Status

900000000000073002 |Sufficiently defined by necessary conditions definition status (core metadata concept)|

Specifies if the concept version is primitive or defined. Set to a descendant of 900000000000444006

Summary

SCTID: 1197400002, Defined, Active

1197400002|Product containing precisely dolutegravir (as dolutegravir sodium) 50 milligram and lamivudine 300 milligram and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 milligram/1 each conventional release oral tablet (clinical drug)|

en Dolutegravir (as dolutegravir sodium) 50 mg and lamivudine 300 mg and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 mg oral tablet
en Product containing precisely dolutegravir (as dolutegravir sodium) 50 milligram and lamivudine 300 milligram and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 milligram/1 each conventional release oral tablet (clinical drug)

Expression

1197400002 |Product containing precisely dolutegravir (as dolutegravir sodium) 50 milligram and lamivudine 300 milligram and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 milligram/1 each conventional release oral tablet (clinical drug)|
 === 421026006 |Conventional release oral tablet (dose form)| + 
732936001 |Tablet (unit of presentation)| + 
1197402005 |Product containing only dolutegravir and lamivudine and tenofovir in oral dose form (medicinal product form)| : 
        { 732943007 |Has basis of strength substance (attribute)| = 386897000 |Lamivudine (substance)|,
762949000 |Has precise active ingredient (attribute)| = 386897000 |Lamivudine (substance)|,
732947008 |Has presentation strength denominator unit (attribute)| = 732936001 |Tablet (unit of presentation)|,
732945000 |Has presentation strength numerator unit (attribute)| = 258684004 |Milligram (qualifier value)| }
        { 732943007 |Has basis of strength substance (attribute)| = 421203005 |Tenofovir disoproxil (substance)|,
762949000 |Has precise active ingredient (attribute)| = 385556006 |Tenofovir disoproxil fumarate (substance)|,
732947008 |Has presentation strength denominator unit (attribute)| = 732936001 |Tablet (unit of presentation)|,
732945000 |Has presentation strength numerator unit (attribute)| = 258684004 |Milligram (qualifier value)| }
        { 732943007 |Has basis of strength substance (attribute)| = 713464000 |Dolutegravir (substance)|,
762949000 |Has precise active ingredient (attribute)| = 713465004 |Dolutegravir sodium (substance)|,
732947008 |Has presentation strength denominator unit (attribute)| = 732936001 |Tablet (unit of presentation)|,
732945000 |Has presentation strength numerator unit (attribute)| = 258684004 |Milligram (qualifier value)| }
        

Diagram

Active

Component help	Language Code help	Type	Term help	Case Significance help	Acceptability	Active
4696560013 - Dolutegravir (as dolutegravir sodium) 50 mg and lamivudine 300 mg and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 mg oral tablet (en) View
4696560013	en	Synonym (core metadata concept)	Dolutegravir (as dolutegravir sodium) 50 mg and lamivudine 300 mg and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 mg oral tablet	900000000000448009 \|Entire term case insensitive (core metadata concept)\|	Preferred	True
4696205017 - Product containing precisely dolutegravir (as dolutegravir sodium) 50 milligram and lamivudine 300 milligram and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 milligram/1 each conventional release oral tablet (clinical drug) (en) View
4696205017	en	Fully specified name (core metadata concept)	Product containing precisely dolutegravir (as dolutegravir sodium) 50 milligram and lamivudine 300 milligram and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 milligram/1 each conventional release oral tablet (clinical drug)	900000000000448009 \|Entire term case insensitive (core metadata concept)\|	Preferred	True

Type help	Destination help	Relationship group help	Characteristic type help	Active
Relationship (15029450029) - 1197400002 -> 788073005 (766939001) View
766939001 \|Plays role (attribute)\|	788073005 \|Antiretroviral therapeutic role (role)\|	0	900000000000011006 \|Inferred relationship (core metadata concept)\|	False
Relationship (15029446020) - 1197400002 -> 1197402005 (116680003) View
116680003 \|Is a (attribute)\|	1197402005 \|Product containing only dolutegravir and lamivudine and tenofovir in oral dose form (medicinal product form)\|	0	900000000000011006 \|Inferred relationship (core metadata concept)\|	True
Relationship (15029447027) - 1197400002 -> 421026006 (411116001) View
411116001 \|Has dose form (attribute)\|	421026006 \|Conventional release oral tablet (dose form)\|	0	900000000000011006 \|Inferred relationship (core metadata concept)\|	True
Relationship (15029448021) - 1197400002 -> 732936001 (763032000) View
763032000 \|Has unit of presentation (attribute)\|	732936001 \|Tablet (unit of presentation)\|	0	900000000000011006 \|Inferred relationship (core metadata concept)\|	True
Relationship (15029451025) - 1197400002 -> 386897000 (762949000) View
762949000 \|Has precise active ingredient (attribute)\|	386897000 \|Lamivudine (substance)\|	1	900000000000011006 \|Inferred relationship (core metadata concept)\|	True
Relationship (15029452021) - 1197400002 -> 386897000 (732943007) View
732943007 \|Has basis of strength substance (attribute)\|	386897000 \|Lamivudine (substance)\|	1	900000000000011006 \|Inferred relationship (core metadata concept)\|	True
Relationship (15029454022) - 1197400002 -> 258684004 (732945000) View
732945000 \|Has presentation strength numerator unit (attribute)\|	258684004 \|Milligram (qualifier value)\|	1	900000000000011006 \|Inferred relationship (core metadata concept)\|	True
Relationship (15029456024) - 1197400002 -> 732936001 (732947008) View
732947008 \|Has presentation strength denominator unit (attribute)\|	732936001 \|Tablet (unit of presentation)\|	1	900000000000011006 \|Inferred relationship (core metadata concept)\|	True
Relationship (15029457026) - 1197400002 -> 385556006 (762949000) View
762949000 \|Has precise active ingredient (attribute)\|	385556006 \|Tenofovir disoproxil fumarate (substance)\|	2	900000000000011006 \|Inferred relationship (core metadata concept)\|	True
Relationship (15029458020) - 1197400002 -> 421203005 (732943007) View
732943007 \|Has basis of strength substance (attribute)\|	421203005 \|Tenofovir disoproxil (substance)\|	2	900000000000011006 \|Inferred relationship (core metadata concept)\|	True
Relationship (15029460022) - 1197400002 -> 258684004 (732945000) View
732945000 \|Has presentation strength numerator unit (attribute)\|	258684004 \|Milligram (qualifier value)\|	2	900000000000011006 \|Inferred relationship (core metadata concept)\|	True
Relationship (15029462025) - 1197400002 -> 732936001 (732947008) View
732947008 \|Has presentation strength denominator unit (attribute)\|	732936001 \|Tablet (unit of presentation)\|	2	900000000000011006 \|Inferred relationship (core metadata concept)\|	True
Relationship (15029463024) - 1197400002 -> 713465004 (762949000) View
762949000 \|Has precise active ingredient (attribute)\|	713465004 \|Dolutegravir sodium (substance)\|	3	900000000000011006 \|Inferred relationship (core metadata concept)\|	True
Relationship (15029464029) - 1197400002 -> 713464000 (732943007) View
732943007 \|Has basis of strength substance (attribute)\|	713464000 \|Dolutegravir (substance)\|	3	900000000000011006 \|Inferred relationship (core metadata concept)\|	True
Relationship (15029466027) - 1197400002 -> 258684004 (732945000) View
732945000 \|Has presentation strength numerator unit (attribute)\|	258684004 \|Milligram (qualifier value)\|	3	900000000000011006 \|Inferred relationship (core metadata concept)\|	True
Relationship (15029468026) - 1197400002 -> 732936001 (732947008) View
732947008 \|Has presentation strength denominator unit (attribute)\|	732936001 \|Tablet (unit of presentation)\|	3	900000000000011006 \|Inferred relationship (core metadata concept)\|	True

Fully Specified Name (FSN)	Shortest Term	Definition Status help	Active
1197402005 View
1197402005	Product containing only dolutegravir and lamivudine and tenofovir in oral dose form (medicinal product form)	Dolutegravir and lamivudine and tenofovir only product in oral dose form	900000000000073002 \|Sufficiently defined by necessary conditions definition status (core metadata concept)\|	True
421026006 View
421026006	Conventional release oral tablet (dose form)	Oral tablet	900000000000073002 \|Sufficiently defined by necessary conditions definition status (core metadata concept)\|	True
732936001 View
732936001	Tablet (unit of presentation)	Tablet	900000000000074008 \|Necessary but not sufficient concept definition status (core metadata concept)\|	True

Fully Specified Name (FSN)	Shortest Term	Definition Status help	Active

Reference Set help	Map Target help	Map Rule help	Map Advice help	Correlation help	Map Category help

Terminology chevron_right Concepts chevron_right 1197400002

Descriptions

Relationships

Parent Concepts

Children Concepts

Extended Maps

Recent searches